Authors
Loading...
Systematic review uncovers increased odds of cerebral meningioma with depot medroxyprogesterone acetate exposure, indicating a need for patient discussions regarding risks.
Reynolds et al. (2026) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: